Crypto Millionaire: “Pay Attention to May 20th”

From Investor Place Media | Ad

Charlie Shrem is like the “Godfather of Cryptocurrencies”. He discovered Bitcoin when it was trading for $5. Ethereum at $109. Binance at just $6. Cardano for 5 CENTS.

Today, he’s sharing the details of a $0.21 CENT crypto with Top 5 Potential… as well as his BIG prediction for May 20th.

Get the details NOW.

ABCL Insider Trading (AbCellera Biologics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 45.80%

Insider Buying (Last 12 Months): $16,891,992.98

Insider Selling (Last 12 Months): $340,716,933.15

AbCellera Biologics Insider Trading History Chart

AbCellera Biologics Share Price & Price History

^$7.98

▲ +0.17 (2.18%)

As of 05/17/2022 01:58 PM ET

Days: 30 | 90 | 365

"new normal coming"???

From Legacy Research | Ad

PhD who walked away from her million-dollar career at Goldman Sachs says "Strange new normal coming"

Learn more.

AbCellera Biologics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/12/2022	Andrew Booth	CFO	Buy	85,000	$5.79	$492,150.00	138,500
5/12/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	1,408,468	$6.41	$9,028,279.88	55,215,758
3/4/2022	John S. Montalbano	Director	Buy	10,000	$8.54	$85,400.00
3/1/2022	John S. Montalbano	Director	Buy	20,000	$9.05	$181,000.00
2/28/2022	Veronique Lecault	COO	Buy	230,789	$8.66	$1,998,632.74
12/3/2021	Andrew Lo	Director	Buy	86,938	$14.02	$1,218,870.76
11/11/2021	Andrew Booth	CFO	Buy	53,500	$14.74	$788,590.00
11/11/2021	Holdings Ltd. Thermopylae	Major Shareholder	Buy	202,960	$14.76	$2,995,689.60
8/31/2021	John Hamer	Director	Sell	162,649	$16.95	$2,756,900.55
8/16/2021	John S. Montalbano	Director	Buy	6,000	$17.23	$103,380.00
6/22/2021	Michael R. Hayden	Director	Sell	100,000	$25.50	$2,550,000.00
6/9/2021	Andrew Booth	CFO	Sell	1,200,000	$25.50	$30,600,000.00
6/9/2021	Carl L. G. Hansen	CEO	Sell	6,000,000	$24.13	$144,780,000.00
6/9/2021	Holdings Ltd. Thermopylae	Major Shareholder	Sell	5,598,420	$24.03	$134,530,032.60	55,604,330
6/9/2021	Veronique Lecault	COO	Sell	1,000,000	$25.50	$25,500,000.00	1,006,000

"The Most Critical Metal for Global Economies"

From Investing Trends | Ad

The soaring demand for this "red rock" may be the most important development in 2022. It's key in the transition to the new green energy economies. Bloomberg News warns… "Within a decade, the world may face a massive shortfall of what's arguably the most critical metal for global economies." Copper prices have nearly doubled in the past year.

Find Out How This Is Good News

SEC Filings (Institutional Ownership Changes) for AbCellera Biologics (NASDAQ:ABCL)

39.58% of AbCellera Biologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbCellera Biologics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/17/2022	Polar Asset Management Partners Inc.	628,130	$6.12M	0.1%	N/A	0.221%
5/17/2022	Royal Bank of Canada	827,293	$8.07M	0.0%	-2.0%	0.291%
5/17/2022	SB Management Ltd	7,764,299	$75.70M	14.7%	-20.9%	2.729%
5/17/2022	Stansberry Asset Management LLC	102,963	$1M	0.2%	+7.3%	0.036%
5/17/2022	Delphia USA Inc.	16,348	$0.16M	0.1%	N/A	0.006%
5/17/2022	Dynamic Technology Lab Private Ltd	31,427	$0.31M	0.0%	N/A	0.011%
5/16/2022	Goldman Sachs Group Inc.	112,725	$1.10M	0.0%	-16.8%	0.040%
5/16/2022	Woodline Partners LP	136,910	$1.34M	0.0%	-79.6%	0.048%
5/16/2022	State Street Corp	269,030	$2.62M	0.0%	+50.1%	0.095%
5/16/2022	UBS Group AG	62,425	$0.61M	0.0%	-21.2%	0.022%
5/13/2022	Renaissance Technologies LLC	2,617,603	$25.52M	0.0%	+385.5%	0.920%
5/13/2022	Brandywine Managers LLC	40,091	$0.39M	0.7%	+7.6%	0.014%
5/13/2022	Lazard Asset Management LLC	3,189,837	$31.10M	0.0%	+997.1%	1.121%
5/13/2022	Worth Asset Management LLC	3,750	$25K	0.0%	N/A	0.001%
5/13/2022	XTX Topco Ltd	14,040	$0.14M	0.1%	N/A	0.005%
5/13/2022	Federated Hermes Inc.	1,288,000	$12.56M	0.0%	+55.6%	0.453%
5/13/2022	Allianz Asset Management GmbH	11,158,045	$108.79M	0.1%	-0.1%	3.922%
5/13/2022	Canada Pension Plan Investment Board	393,776	$3.84M	0.0%	-9.6%	0.138%
5/12/2022	Cibc World Market Inc.	28,900	$0.28M	0.0%	-27.7%	0.010%
5/12/2022	BlackRock Inc.	2,447,299	$23.86M	0.0%	+3.4%	0.860%
5/12/2022	Quent Capital LLC	24,550	$0.24M	0.0%	+16.6%	0.009%
5/12/2022	Acadian Asset Management LLC	29,123	$0.28M	0.0%	N/A	0.010%
5/12/2022	Citigroup Inc.	11,022	$0.11M	0.0%	-97.1%	0.004%
5/12/2022	Blueshift Asset Management LLC	32,574	$0.32M	0.0%	N/A	0.011%
5/11/2022	Raymond James & Associates	15,992	$0.16M	0.0%	-78.0%	0.006%
5/11/2022	JPMorgan Chase & Co.	150,882	$1.47M	0.0%	+83.9%	0.053%
5/11/2022	GSA Capital Partners LLP	16,988	$0.17M	0.0%	N/A	0.006%
5/11/2022	CTC Capital Management LLC	16,000	$0.16M	0.4%	N/A	0.006%
5/10/2022	ProShare Advisors LLC	29,483	$0.29M	0.0%	-25.6%	0.010%
5/10/2022	Fox Run Management L.L.C.	24,366	$0.24M	0.1%	N/A	0.009%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	16,008	$0.16M	0.0%	+13.1%	0.006%
5/9/2022	Qube Research & Technologies Ltd	149,417	$1.46M	0.0%	+659.5%	0.053%
5/5/2022	Gryphon Financial Partners LLC	10,490	$0.10M	0.0%	N/A	0.004%
5/5/2022	Baillie Gifford & Co.	11,048,765	$107.73M	0.1%	+209.2%	3.883%
5/4/2022	Advisor Group Holdings Inc.	40,699	$0.40M	0.0%	+51.7%	0.014%
5/4/2022	abrdn plc	410,452	$4M	0.0%	-12.7%	0.145%
4/29/2022	Cornerstone Investment Partners LLC	19,025	$0.19M	0.0%	N/A	0.007%
4/29/2022	Gruss & Co. LLC	286,000	$2.79M	12.4%	-33.0%	0.101%
4/29/2022	C M Bidwell & Associates Ltd.	11,625	$0.11M	0.1%	N/A	0.004%
4/28/2022	DekaBank Deutsche Girozentrale	187,000	$1.82M	0.0%	-4.1%	0.066%
4/26/2022	Belmont Capital LLC	100,000	$0.98M	1.0%	-33.3%	0.035%
4/20/2022	Belvedere Trading LLC	19,810	$0.17M	0.0%	N/A	0.007%
4/19/2022	Green Alpha Advisors LLC	34,013	$0.33M	0.2%	+20.8%	0.012%
4/18/2022	Rothschild Investment Corp IL	33,000	$0.32M	0.0%	+26.9%	0.012%
4/6/2022	Cedar Brook Financial Partners LLC	16,965	$0.17M	0.0%	+44.8%	0.006%
3/9/2022	Norges Bank	285,369	$4.08M	0.0%	N/A	0.101%
2/23/2022	BlackRock Inc.	2,367,242	$33.85M	0.0%	+142.4%	0.841%
2/19/2022	Wells Fargo & Company MN	92,183	$1.32M	0.0%	-37.0%	0.033%
2/19/2022	Woodline Partners LP	670,639	$9.59M	0.1%	+69.0%	0.238%
2/17/2022	Goldman Sachs Group Inc.	135,449	$1.94M	0.0%	+622.6%	0.048%
2/16/2022	Allianz Asset Management GmbH	11,165,010	$159.66M	0.1%	-5.9%	3.965%
2/16/2022	Parametric Portfolio Associates LLC	2,000,000	$28.60M	0.0%	+17.6%	0.710%
2/15/2022	Bullseye Asset Management LLC	17,766	$0.25M	0.1%	-36.1%	0.006%
2/15/2022	Stansberry Asset Management LLC	95,915	$1.37M	0.2%	+146.1%	0.034%
2/15/2022	Stifel Financial Corp	38,821	$0.56M	0.0%	-45.0%	0.014%
2/15/2022	Millennium Management LLC	696,361	$9.96M	0.0%	-17.9%	0.247%
2/15/2022	CIBC World Markets Inc.	39,953	$0.57M	0.0%	-48.3%	0.014%
2/15/2022	Credit Agricole S A	9,600	$0.14M	0.0%	+45.5%	0.003%
2/15/2022	Capital International Investors	8,131,951	$116.29M	0.0%	+14.4%	2.888%
2/15/2022	Capital World Investors	22,051,703	$315.34M	0.0%	+11.3%	7.831%
2/15/2022	Cubist Systematic Strategies LLC	262,686	$3.76M	0.0%	+612.4%	0.093%
2/14/2022	Canada Pension Plan Investment Board	435,400	$6.23M	0.0%	N/A	0.155%
2/14/2022	Virtus ETF Advisers LLC	12,482	$0.18M	0.1%	+44.1%	0.004%
2/14/2022	Squarepoint Ops LLC	80,281	$1.15M	0.0%	+42.0%	0.029%
2/14/2022	Alliancebernstein L.P.	125,000	$1.79M	0.0%	N/A	0.044%
2/14/2022	State Street Corp	179,207	$2.56M	0.0%	+41.7%	0.064%
2/14/2022	Goldman Sachs Group Inc.	135,449	$1.94M	0.0%	+622.6%	0.048%
2/14/2022	ETF Managers Group LLC	85,105	$1.22M	0.0%	-16.4%	0.030%
2/14/2022	Gotham Asset Management LLC	28,415	$0.41M	0.0%	-61.1%	0.010%
2/11/2022	Geode Capital Management LLC	201,868	$2.89M	0.0%	+537.5%	0.072%
2/11/2022	Renaissance Technologies LLC	539,203	$7.71M	0.0%	+539.6%	0.191%
2/11/2022	Pentwater Capital Management LP	137,500	$1.97M	0.0%	+34.1%	0.049%
2/11/2022	Allianz Asset Management GmbH	11,165,010	$159.66M	0.1%	-5.9%	3.965%
2/11/2022	Bank of Montreal Can	102,974	$1.50M	0.0%	-9.1%	0.037%
2/10/2022	abrdn plc	470,278	$6.73M	0.0%	+10.4%	0.167%
2/10/2022	Brandywine Managers LLC	37,264	$0.53M	0.6%	+21.3%	0.013%
2/10/2022	JPMorgan Chase & Co.	82,038	$1.17M	0.0%	N/A	0.029%
2/10/2022	Qube Research & Technologies Ltd	19,673	$0.28M	0.0%	N/A	0.007%
2/9/2022	EPIQ Capital Group LLC	92,358	$1.32M	0.2%	-35.4%	0.033%
2/9/2022	Lazard Asset Management LLC	290,746	$4.16M	0.0%	+106.2%	0.103%
2/8/2022	Bank of America Corp DE	4,108	$59K	0.0%	+67.9%	0.001%
2/8/2022	Raymond James & Associates	72,726	$1.04M	0.0%	-42.4%	0.026%
2/8/2022	ProShare Advisors LLC	39,653	$0.57M	0.0%	N/A	0.014%
2/8/2022	abrdn plc	470,278	$6.73M	0.0%	+10.4%	0.167%
2/7/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	14,154	$0.20M	0.0%	+100.5%	0.005%
2/3/2022	Cambridge Investment Research Advisors Inc.	45,763	$0.65M	0.0%	+7.9%	0.016%
2/3/2022	Advisor Group Holdings Inc.	26,822	$0.38M	0.0%	+105.0%	0.010%
2/3/2022	JFS Wealth Advisors LLC	26,064	$0.37M	0.0%	N/A	0.009%
2/2/2022	DekaBank Deutsche Girozentrale	195,000	$2.65M	0.0%	N/A	0.069%
2/1/2022	Renaissance Capital LLC	10,327	$0.15M	0.0%	-14.9%	0.004%
2/1/2022	Nomura Asset Management Co. Ltd.	54,830	$0.78M	0.0%	N/A	0.019%
2/1/2022	Qube Research & Technologies Ltd	19,673	$0.28M	0.0%	N/A	0.007%
1/31/2022	Commonwealth Equity Services LLC	15,835	$0.23M	0.0%	-19.3%	0.006%
1/31/2022	Gruss & Co. LLC	426,966	$6.11M	16.4%	-0.8%	0.152%
1/28/2022	Moloney Securities Asset Management LLC	13,100	$0.19M	0.0%	-40.7%	0.005%
1/27/2022	Cedar Brook Financial Partners LLC	11,715	$0.17M	0.0%	N/A	0.004%
1/27/2022	Janney Montgomery Scott LLC	183,697	$2.63M	0.0%	+17.6%	0.065%
1/24/2022	Rothschild Investment Corp IL	26,000	$0.37M	0.0%	N/A	0.009%
1/21/2022	Eagle Bay Advisors LLC	4,463	$85K	0.1%	+44.0%	0.002%
1/20/2022	Baillie Gifford & Co.	3,573,908	$51.11M	0.0%	+10.3%	1.269%

Data available starting January 2016

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Today's Range

Now: $7.98

$7.80

$8.23

50 Day Range

MA: $8.50

$5.72

$10.41

52 Week Range

Now: $7.98

$5.42

$36.05

Volume

55,104 shs

Average Volume

2,009,382 shs

Market Capitalization

$2.27 billion

P/E Ratio

12.47

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of AbCellera Biologics?: AbCellera Biologics' top insider shareholders include:
Holdings Ltd Thermopylae (Major Shareholder)
Veronique Lecault (COO)
Andrew Booth (CFO)
Andrew Lo (Director)
Carl L G Hansen (CEO)
John Hamer (Director)
John S Montalbano (Director)
Michael R Hayden (Director)
Learn More about top insider investors at AbCellera Biologics.
Who are the major institutional investors of AbCellera Biologics?: AbCellera Biologics' top institutional shareholders include:
Allianz Asset Management GmbH — 3.92%
Baillie Gifford & Co. — 3.88%
SB Management Ltd — 2.73%
Lazard Asset Management LLC — 1.12%
Renaissance Technologies LLC — 0.92%
BlackRock Inc. — 0.86%
Learn More about top institutional investors of AbCellera Biologics stock.
Which major investors are selling AbCellera Biologics stock?: Within the last quarter, ABCL stock was sold by these institutional investors:
SB Management Ltd
Woodline Partners LP
Citigroup Inc.
Group One Trading L.P.
Gruss & Co. LLC
abrdn plc
Raymond James & Associates
Belmont Capital LLC
Within the last year, company insiders that have sold AbCellera Biologics company stock include:
Holdings Ltd Thermopylae (Major Shareholder)
Veronique Lecault (COO)
Andrew Booth (CFO)
Andrew Lo (Director)
Carl L G Hansen (CEO)
John Hamer (Director)
Learn More investors selling AbCellera Biologics stock.
Which major investors are buying AbCellera Biologics stock?: Within the previous quarter, ABCL stock was purchased by institutional investors including:
Baillie Gifford & Co.
Lazard Asset Management LLC
Renaissance Technologies LLC
Polar Asset Management Partners Inc.
Federated Hermes Inc.
Qube Research & Technologies Ltd
Simplex Trading LLC
State Street Corp
During the last year, these company insiders have bought AbCellera Biologics stock:
Holdings Ltd Thermopylae (Major Shareholder)
Veronique Lecault (COO)
Andrew Booth (CFO)
Andrew Lo (Director)
Carl L G Hansen (CEO)
Learn More investors buying AbCellera Biologics stock.

The U.S. Solution to China's Copper Grab